Cargando…

Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure

BACKGROUND: Disease progression in heart failure (HF) reflects derangements in neurohormonal systems, and biomarkers of these systems can help to establish the diagnosis and assess the prognosis. Serial measurements of the precursor peptides of the natriuretic and vasopressin systems (midregional pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Wayne L, Hartman, Karen A, Grill, Diane E, Struck, Joachim, Bergmann, Andreas, Jaffe, Allan S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2011
Materias:	Biomarkers and Heart Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276775/ https://www.ncbi.nlm.nih.gov/pubmed/22194151 http://dx.doi.org/10.1136/heartjnl-2011-300823

Ejemplares similares

Comparative accuracy of NT‐proBNP and MR‐proANP for the diagnosis of acute heart failure in dyspnoeic patients
por: Darche, Fabrice F., et al.
Publicado: (2017)

Variability of biomarkers in patients with chronic heart failure and healthy controls
por: Meijers, Wouter C., et al.
Publicado: (2016)

MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction
por: Jensen, Jesper, et al.
Publicado: (2020)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Biomarkers in Routine Heart Failure Clinical Care
por: Nadar, Sunil K, et al.
Publicado: (2019)

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2011)

Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study
por: Hage, Camilla, et al.
Publicado: (2015)

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
por: Cubbon, Richard M, et al.
Publicado: (2016)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial
por: Maisel, Alan S., et al.
Publicado: (2011)

The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
por: Hoes, Martijn F., et al.
Publicado: (2019)

Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
por: Molvin, John, et al.
Publicado: (2019)

Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure
por: Boorsma, Eva M., et al.
Publicado: (2021)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
por: Henkens, Michiel T.H.M., et al.
Publicado: (2020)

Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM
por: Then, Cornelia, et al.
Publicado: (2016)

MR-proADM and MR-proANP levels in patients with acute pulmonary embolism
por: Öner, Önsel, et al.
Publicado: (2020)

The New Heart Failure Association Definition of Advanced Heart Failure
por: Metra, Marco, et al.
Publicado: (2019)

Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
por: Benini, Annachiara, et al.
Publicado: (2022)

Copeptin and acute renal failure in critically ill patients
por: Meyer, B, et al.
Publicado: (2008)

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study
por: Welsh, Paul, et al.
Publicado: (2017)

Antithrombotics in heart failure
por: Miličić, Davor, et al.
Publicado: (2014)

Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP
por: Behnes, Michael, et al.
Publicado: (2017)

Response to the Letter: The NT‐proANP puzzle ‐ a small piece that makes the big picture
por: Seewöster, Timm, et al.
Publicado: (2020)

Short‐Term Influence of Radiofrequency Ablation on NT‐proBNP, MR‐proANP, Copeptin, and MR‐proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study
por: Charitakis, Emmanouil, et al.
Publicado: (2016)

Management of heart failure with reduced ejection fraction
por: Haydock, Paul M, et al.
Publicado: (2022)

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?
por: Piek, Arnold, et al.
Publicado: (2020)

Copeptin as a predictive marker of incident heart failure
por: Schill, Fredrika, et al.
Publicado: (2021)

Management of patients with heart failure and preserved ejection fraction
por: Jasinska-Piadlo, Alicja, et al.
Publicado: (2023)

Ultrafiltration in Acute Heart Failure
por: Costanzo, Maria Rosa
Publicado: (2019)

VACCINE ASSOCIATED HEART FAILURE
por: Aziz, David, et al.
Publicado: (2022)

Plasma proANP and SDMA and microRNAs are associated with chronic mitral regurgitation in a pig model
por: Cirera, Susanna, et al.
Publicado: (2013)

Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patients
por: Yagmur, Eray, et al.
Publicado: (2019)

FTIR Analysis of Renal Tissue for the Assessment of Hypertensive Organ Damage and proANP(31–67) Treatment
por: Pioppi, Leonardo, et al.
Publicado: (2023)

Prevalence of early stages of heart failure in an elderly risk population: the Copenhagen Heart Failure Risk Study
por: Gaborit, Freja Stoltze, et al.
Publicado: (2019)

An unusual case of systemic amyloid causing constrictive heart failure
por: Mohamed Hoesein, F. A. A., et al.
Publicado: (2016)

Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
por: Guimaraes, Leonardo, et al.
Publicado: (2020)

Gaps in Modern Heart Failure and Chronic Kidney Disease Research
por: Parmar, Simran Singh, et al.
Publicado: (2023)

Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction
por: Guazzi, Marco, et al.
Publicado: (2021)

Hidden in Heart Failure
por: Cannie, Douglas Ewan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4q0et85bsg9qrclcep9kbe7pau